 Connection
Wendy Armstrong to Pyridones
This is a "connection" page, showing publications Wendy Armstrong has written about Pyridones.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.245 |
|
|
|
-
Haser GC, Balter L, Gurley S, Thomas M, Murphy T, Sumitani J, Leue EP, Hollman A, Karneh M, Wray L, Washington M, Corbin-Johnson D, Condra A, Niles-Carnes L, Smith BL, Armstrong WS, Kalokhe AS, Colasanti JA, Collins LF. Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South. AIDS Res Hum Retroviruses. 2024 12; 40(12):690-700.
Score: 0.191
-
Colasanti JA, Aldredge A, Niles-Carnes LV, Ochieng E, Pareek P, Robinson V, Anderson E, Castaneda M, Spralling H, Smith BL, Sumitani J, Paul Leue E, Moran CA, Lora M, Armstrong WS, Collins LF. Long-Acting Cabotegravir/Rilpivirine, Lenacapavir, and Ibalizumab Use Among Persons With HIV-1 Viremia at a Ryan White-Funded Clinic in the Urban US South. Clin Infect Dis. 2026 Apr 30; 82(4):564-574.
Score: 0.054
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|